Production (Stage)
Cidara Therapeutics, Inc.
CDTX
$24.28
-$1.42-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 168.15M | 189.83M | 127.39M | 164.37M | 29.02M |
| Total Receivables | 1.69M | 1.69M | 1.70M | 2.35M | 7.28M |
| Inventory | -- | -- | -- | -- | 7.27M |
| Prepaid Expenses | 12.67M | 12.87M | 27.69M | 1.87M | 3.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.34M | 6.35M | -- | -- | -- |
| Total Current Assets | 188.85M | 210.74M | 156.77M | 168.59M | 46.83M |
|
|
|||||
| Total Current Assets | 188.85M | 210.74M | 156.77M | 168.59M | 46.83M |
| Net Property, Plant & Equipment | 2.78M | 3.96M | 4.32M | 4.67M | 4.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.00K | 96.00K | 1.24M | 104.00K | 987.00K |
| Total Assets | 191.73M | 214.80M | 162.33M | 173.36M | 52.72M |
|
|
|||||
| Total Accounts Payable | 4.90M | 3.61M | 2.97M | 2.29M | 5.06M |
| Total Accrued Expenses | 42.48M | 44.30M | 39.79M | 35.82M | 34.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.44M | 1.64M | 1.58M | 1.52M | 1.46M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 11.00K | 24.32M |
| Total Other Current Liabilities | -- | -- | -- | 11.00K | 24.32M |
| Total Current Liabilities | 48.81M | 49.55M | 44.34M | 39.64M | 65.43M |
|
|
|||||
| Total Current Liabilities | 48.81M | 49.55M | 44.34M | 39.64M | 65.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.24M | 1.93M | 2.36M | 2.78M | 3.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 1.89M |
| Total Liabilities | 50.05M | 51.49M | 46.70M | 42.42M | 70.50M |
|
|
|||||
| Common Stock & APIC | 776.42M | 774.57M | 674.58M | 673.90M | 433.98M |
| Retained Earnings | -634.74M | -611.26M | -558.95M | -542.97M | -451.76M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 141.68M | 163.31M | 115.63M | 130.94M | -17.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 141.68M | 163.31M | 115.63M | 130.94M | -17.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 141.68M | 163.31M | 115.63M | 130.94M | -17.78M |
|
|
|||||